Accuray (ARAY) Reports In-Line Q4 EPS, Beats on Revenue; Offers FY24 Revenue Guidance
Tweet
Share
E-mail
Get Alerts ARAY Hot Sheet
Price: $0.28 --0%
Revenue Growth %: -17.0%
Financial Fact:
Net loss attributable to stockholders: -9.93M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Revenue Growth %: -17.0%
Financial Fact:
Net loss attributable to stockholders: -9.93M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Accuray (NASDAQ: ARAY) reported Q4 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $134.3 million versus the consensus estimate of $121.5 million.
GUIDANCE:
Accuray sees FY2025 revenue of $460-470 million, versus the consensus of $456.4 million.
For earnings history and earnings-related data on Accuray (ARAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
